You are here

News

subscribe

The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.

31 January 2017

Spotlight on supervised drug consumption rooms as the USA looks to open its first facility

As news hits that the USA is to open up its first safer injecting facility – where else in the world do they exist and why are they important for improving health outcomes?

27 January 2017

Discovery of chemical messages between viruses could provide new way to induce HIV latency

One of the first studies into viral communication shows that viruses that infect bacteria (phages) leave chemical messages for each other which help them decide whether to kill or linger. Disrupting these messages could provide a new way to control HIV.

25 January 2017

11 things to expect from an HIV home-test

HIV home-testing kits are available in a growing number of countries. They offer you the convenience of taking an HIV test in your own time and in the privacy of your own home – but are they for everyone?

19 January 2017

Rural and urban patterns of HIV drug resistance in South Africa

HIV is more proactively monitored among urban HIV patients than rural patients, and drug resistance and treatment failure is less prevalent. However outcomes for second line treatment remain similar.

13 January 2017

Vaginal bacteria could play a key role in regulating HIV risk among women

Understanding the vaginal microbiome and how it impacts HIV risk could help develop more effective treatment and prevention strategies for young women in sub-Saharan Africa.

11 January 2017

Interventions to keep people in HIV care more cost-effective than a ‘treat all’ approach

Treatment scale-up has had major public health benefits. But where resources are scarce, interventions to keep people in care could be more cost-effective than moving to treat everybody living with HIV after diagnosis.

06 January 2017

HIV drug resistance: a new threat for low- and middle-income countries

With 17 million people now accessing antiretroviral treatment worldwide, HIV drug resistance has the potential to unravel progress towards the Fast-Track target of ending AIDS by 2030.